Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel tumor-directed oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
View Top Employees from ReplimuneWebsite | http://www.replimune.com |
Ticker | REPL |
Revenue | $69.5 million |
Funding | $376 million |
Employees | 313 (295 on RocketReach) |
Founded | 2015 |
Address | 500 Unicorn Park Dr Fl 3, Woburn, Massachusetts 01801, US |
Phone | (781) 222-9600 |
Technologies |
JavaScript,
HTML,
PHP
+36 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Health Care, Biotechnology, Healthcare, Medical, Therapeutics |
Keywords | Cancer Treatment, Immunotherapy |
Competitors | Atara Biotherapeutics, Evelo Biosciences, Iovance Biotherapeutics Inc, Jounce Therapeutics, Inc., NextCure, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Replimune employee's phone or email?
The Replimune annual revenue was $69.5 million in 2024.
Colin Love is the COO of Replimune.
295 people are employed at Replimune.
Replimune is based in Woburn, Massachusetts.
The NAICS codes for Replimune are [541, 541714, 5417, 54171, 54].
The SIC codes for Replimune are [873, 87].